المؤلفون: 齋藤, 暁, Saito, Akira

مصطلحات موضوعية: 気管支喘息, ソーシャルキャピタル, ACT(Asthma Control Test), アンケート調査

وصف الملف: application/pdf

الوصول الحر: https://ndlsearch.ndl.go.jp/books/R100000039-I12297118Test

Degree: 博士（医学） -- 新潟大学

المؤلفون: Jennifer K. Carroll, Paulina Arias Hernandez, Alicia Brooks-Greisen, Juan Carlos Cardet, Jing Cui, Brianna Ericson, Maureen Fagan, Merritt L. Fajt, Victoria E. Forth, Anne L. Fuhlbrigge, Margie Lorenzi, Jacqueline Rodriguez-Louis, Nancy E. Maher, Brian K. Manning, Wilson D. Pace, Joel B. Shields, Elliot Israel

المصدر: Journal of the National Medical Association

مصطلحات موضوعية: Adult, ASUI, Asthma Symptom Utility Index, PCORI, Patient-Centered Outcomes Research Institute, COVID-19 Vaccines, EDS, Everyday Discrimination Scale, GINA, Global Initiative for Asthma, LTRA, leukotriene receptor antagonist, SAMA, short-acting muscarinic antagonist, Hispanic, ICS, inhaled corticosteroid, H/L, Hispanic/Latinx, Article, Tdap, tetanus/diphtheria/acellular pertussis, Humans, African American, Pandemics, Vaccine hesitancy, CDC, Centers for Disease Control and Prevention, COVID-19, coronavirus disease 2019, AA/B, African American/Black, Socioeconomic impact of COVID-19, COVID-19, Hispanic or Latino, General Medicine, FDA, Food and Drug Administration, HPV, human papilloma virus, PREPARE, PeRson EmPowered Asthma RElief, Asthma, AIDS, acquired immunodeficiency syndrome, Black or African American, Coronavirus, HIV, human immunodeficiency virus, ACT, Asthma Control Test, LABA, long-acting β2-agonist, LAMA, long-acting muscarinic antagonist, Socioeconomic Factors, COPD, chronic obstructive pulmonary disease, NIAID, National Institute of Allergy and Infectious Diseases, SABA, short-acting β2-agonist, SD, standard deviation, Vaccine, HRQOL-4, Healthy Days Core Module

الوصف: Purpose To describe the socioeconomic and healthcare-related effects of the COVID-19 pandemic, and willingness to receive a free COVID-19 vaccine, among African American/Black (AA/B) and Hispanic/Latinx (H/L) adults with asthma currently enrolled in a large trial. Methods The present analysis is a sub-study of the PeRson EmPowered Asthma RElief (PREPARE) study, a pragmatic study of 1201 AA/B and H/L adults with asthma. A monthly questionnaire was completed by a subset of PREPARE participants (n = 325) during May–August, 2020. The 5-item questionnaire assessed self-reported impact of COVID-19 on respondents’ ability to obtain asthma medications, medical care quality, employment, income and ability to pay bills; and willingness to get a free COVID-19 vaccine. Bivariate analysis and multivariate logistic regression were performed to investigate factors associated with vaccine hesitancy. Results Of 325 survey respondents (25% AA/B, 75% H/L), the majority reported no impact of COVID-19 on medical care or ability to get asthma medications. Approximately half of employed respondents experienced a lower level of employment or job loss, and approximately half reported having difficulty paying bills during the pandemic. Thirty-five percent of respondents reported unwillingness and 31% reported being somewhat likely to receive a free COVID-19 vaccine. AA/B race/ethnicity and poorer reported physical health were associated with a higher likelihood of COVID-19 vaccine hesitancy. Conclusion AA/B and H/L adults with asthma may experience changes in the quality of their asthma care and increased socioeconomic stressors as a result of the COVID-19 pandemic and may be hesitant or unwilling to receive a COVID-19 vaccine.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5164348208b2ce12d57fb0bdd80380fTest
https://doi.org/10.1016/j.jnma.2021.12.010Test

المؤلفون: Saito, Akira

المصدر: 新潟医学会雑誌. 135(4-6):43-52

مصطلحات موضوعية: ソーシャルキャピタル, 気管支喘息, アンケート調査, ACT(Asthma Control Test)

الوصف: ソーシャルキャピタルは，社会組織の重要性を説明する概念である．ソーシャルキャピタルと慢性疾患の関連はいくつか報告されているが，喘息コントロールとソーシャルキャピタルの関係は明らかでない．今回，我々は，アンケート調査を用いて喘息コントロールとソーシャルキャピタルの関係を調査した新潟県内の医療機関に通院している喘息患者とその主治医を対象に，2016年9月から10月にかけて横断的な喘息コントロール状況，治療内容などのアンケート調査を実施した．個々のソーシャルキャピタルは，日本老年学的評価研究機構(JAGES : Japan Gerontological Evaluation Study)のソーシャルキャピタル測定法を用いて評価した解析対象は，1,659人で，喘息コントロールテスト(ACT : Asthma Control Test)でコントロール良好群(ACT ≥ 23)は898名，コントロール不十分群(ACT < 23)は761名であった．コントロール不十分群では，コントロール良好群と比較して有意に，喫煙歴およびASK-12(Adherence Starts with Knowledge-12)は高く，重症の割合が多く，より多くの治療薬が使用されていた．ソーシャルキャピタルは，コントロール良好群でより高く，特に社会的連帯の項目においては，コントロール良好群では，コントロール不十分群よりも明らかに良好であった．名義ロジスティック解析により，BMI(Body Mass Index)，喫煙，ASK-12は喘息コントロールに独立した関連因子であることを示した．それに加えて，ソーシャルキャピタルの社会的連帯は，喘息コントロールに独立した関連因子であることを示した．ソーシャルキャピタル良好群とソーシャルキャピタル不十分群を比較した解析では，ソーシャルキャピタル良好群ではソーシャルキャピタル不十分群と比較して，喫煙率，ASK-12，重症の割合は低く，ACTスコアは高い結果であった．以上より，喘息コントロールに関与する要因として，ソーシャルキャピタルなどの社会背景は重要であると考えられた．

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=jairo_______::8b68da21865d99b19b1b8d115b091bcdTest
https://niigata-u.repo.nii.ac.jp/records/2000435Test

المؤلفون: Kassim M. Sultan, Muhammed W. Al.Obaidy, Ahmed H. Jaber

المصدر: مجلة كلية الطب, Vol 58, Iss 1 (2016)

مصطلحات موضوعية: (ACT): Asthma Control Test.(GINA) Global initiative for asthma., Medicine, Medicine (General), R5-920

الوصف: Background: The gold standard in assessing asthma control is the Global Initiative for Asthma (GINA) criteria. And because of the difficulties of access to pulmonary functions tests, The ACT has the added advantage that it does not require lung function assessment. Objectives: The aim of this study is to assess asthma control through ACT score and GINA guideline, and to determine if the ACT can be as useful as the GINA-guidelines criteria in assessing asthma control in Iraq. Patient and method: Cross sectional study with comparing ACT vs. GINA guideline in control of asthma level. This study was conducted at Respiratory consultation unit of the Iraqi National center of early detection of Cancer, Baghdad-Iraq, The study was conducted during the period from 1stNovember 2012 to 1stJuly 2013. A total of 71 adult asthmatic patients who were attended to the respiratory consultant unit were asked to participate and were enrolled in this study regardless their age or gender. Their asthma diagnosed and proved clinically by a combination of history, clinical finding In addition objective measurements using spirometry(FEV1) measured by the reversibility test which is defined as(an increment of>12% or 200 ml of FEV1 after 20 minutes of administration of inhaled short acting B2-agonist). Result: There were 71 patients enrolled in this study, of them 66 (92.96%) had an ACT score of ≤ 19 ((26) (39.4%) are male),(40)(60.6%) are female ,and 5 patients (7.04%) had an ACT score of > 19 (only(1) (20.0%) is male and and(4)(80.0%) are female. It had been found the number of male is( 27)and(26)(39.4%) out of them had an ACT19 and number of female is(44),(40)(60.6%)out of them had ACT19. No significant differences had been found in between those patients with ≤19 ACT score vs. those with > 19, regarding the age and gender, in both comparison P>0.05 it had been found that good agreement present between ACT and GINA, 92.9%.ACT agreed the GINA in (37 patients with uncontrolled asthma, 24 patients with partially controlled and 5 patients with controlled). Conclusion: ACT can serve as an alternative diagnostic tool in assessing asthma control even without an aid of a spirometer or a peak flow meter. An ACT score of more than 19 can classify patient as controlled asthmatic while an ACT score < 19 can classify the patient as uncontrolled and partially controlled asthmatics.

وصف الملف: electronic resource

العلاقة: http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/184Test; https://doaj.org/toc/0041-9419Test; https://doaj.org/toc/2410-8057Test

الوصول الحر: https://doaj.org/article/928cbd2aa17e4547ab01f067b54beae9Test

المؤلفون: Sharmilee M. Nyenhuis, Barbara J. Polivka, Luz Huntington-Moskos, Kamal Eldeirawi

المصدر: The Journal of Allergy and Clinical Immunology. in Practice

مصطلحات موضوعية: Adult, medicine.medical_specialty, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), GCAS, Global COVID-19 and Asthma Study, Asthma control, Surveys and Questionnaires, medicine, Immunology and Allergy, Humans, Asthma, MES, Mask Effects Scale, business.industry, SARS-CoV-2, Masks, COVID-19, medicine.disease, Face coverings, United States, Coronavirus, ACT, Asthma Control Test, Physical therapy, Original Article, BMI, Body Mass Index, business, Asthma Control Test

الوصف: Background While masks are recommended for those with asthma in the era of COVID-19, there is limited research exploring the extent of and problems related to mask use in adults with asthma. Objective We sought to describe in adults with asthma: 1) the extent masks are worn and attitudes and beliefs about wearing masks; (2) participant characteristics associated with problems experienced while wearing a mask, and (3) participant experiences and recommendations regarding masks. Methods The Mask Use in Adults with Asthma online survey was conducted with 501 adults with asthma primarily (96.6%) from the United States. A Mask Effects Scale (MES) was compiled from items addressing problems experienced wearing a mask with higher total scores indicating more problems. Open-ended questions explored factors considered when choosing a mask, problems experienced while wearing a mask, and recommendations to others with asthma. Survey data were analyzed descriptively and via multiple regression. Themes were generated from open-ended items. Results Almost all participants (98.4%) indicated wearing a mask in public and most (67.4%) wore a mask ≤3 hours per day. Poorer asthma control and wearing a mask longer were significantly associated with higher MES scores (P≤.001 & .005, respectively). Participant recommendations included “Just wear it”, use a comfortable, well-fitting mask, take mask breaks, and carry your inhaler. Conclusions Wearing a mask in public was almost uniformly adhered to by participants, despite reporting problematic effects. Implementing recommendations, such as planned mask breaks, can support and enhance the experience of wearing a mask for adults with asthma.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb3cb90a2e64b84213369a11b5fe544eTest
https://pubmed.ncbi.nlm.nih.gov/34785392Test

المؤلفون: Diego Bagnasco, Massimiliano Povero, Lorenzo Pradelli, Luisa Brussino, Giovanni Rolla, Marco Caminati, Francesco Menzella, Enrico Heffler, Giorgio Walter Canonica, Pierluigi Paggiaro, Gianenrico Senna, Manlio Milanese, Carlo Lombardi, Caterina Bucca, Andrea Manfredi, Rikki Frank Canevari, Giovanni Passalacqua, Gabriella Guarnieri, Vincenzo Patella, Foschino Barbaro Maria Pia, Elisiana Carpagnano, Anna del Colle, Giulia Scioscia, Pelaia Gerolamo, Manuela Latorre, Francesca Puggioni, Francesca Racca, Elisabetta Favero, Sandra Iannacone, Eleonora Savi, Marcello Montagni, Gianna Camiciottoli, Chiara Allegrini, Giuseppe Spadaro, Caterina Detoraki, Carla Galeone, Patrizia Ruggiero, Monna Rita Yacoub, Alvise Berti, Gisella Colombo, Nicola Scichilone, Carmen Durante, Maria Teresa Costantino, Chiara Roncallo, Mariachiara Braschi, Francesco Blasi, Alice D'Adda, Erminia Ridolo, Massimo Triggiani, Roberta Parente, D'Amato Maria, Maria Vittoria Verrillo, Zappa Maria Cristina, Marianna Lilli, Nunzio Crimi, Marco Bonavia, Angelo Guido Corsico, Amelia Grosso, Stefano Del Giacco, Margherita Deidda, Luisa Ricciardi, Stefania Isola, Francesca Cicero, Giuliana Amato, Federica Vita, Antonio Spanevello, Patrizia Pignatti, Francesca Cherubino, Dina Visca, Eleonora Aletti, Fabio Luigi Massimo Ricciardolo, Vitina Maria Anna Carriero, Francesca Bertolini, Pierachille Santus, Roberta Barlassina, Andrea Airoldi, Giuseppe Guida, Nucera Eleonora, Arianna Aruanno, Angela Rizzi, Cristiano Caruso, Stefania Colantuono, Alessandra Arcolaci, Andrea Vianello, Fulvia Chieco Bianchi, Maria Rita Marchi, Stefano Centanni, Simone Luraschi, Silvia Ruggeri, Rocco Rinaldo, Elena Parazzini, Cecilia Calabrese, Martina Flora, Lorenzo Cosmi, Linda Di Pietro, Enrico Maggi, Laura Pini, Luigi Macchia, Danilo Di Bona, Luca Richeldi, Carola Condoluci, Leonello Fuso, Matteo Bonini, Alessandro Farsi, Giulia Carli, Paolo Montuschi, Giuseppe Santini, Maria Elisabetta Conte, Elisa Turchet, Carlo Barbetta, Francesco Mazza, Simona D'Alo, Stefano Pucci, Maria Filomena Caiaffa, Elena Minenna, Luciana D'Elia, Carlo Pasculli, Vittorio Viviano, Paolo Tarsia, Joyce Rolo, Mariacarmela Di Proietto, Salvatore Lo Cicero

المساهمون: Bagnasco, D., Povero, M., Pradelli, L., Brussino, L., Rolla, G., Caminati, M., Menzella, F., Heffler, E., Canonica, G. W., Paggiaro, P., Senna, G., Milanese, M., Lombardi, C., Bucca, C., Manfredi, A., Canevari, R. F., Passalacqua, G., Guarnieri, G., Patella, V., Maria Pia, F. B., Carpagnano, E., Colle, A. D., Scioscia, G., Gerolamo, P., Latorre, M., Puggioni, F., Racca, F., Favero, E., Iannacone, S., Savi, E., Montagni, M., Camiciottoli, G., Allegrini, C., Spadaro, G., Detoraki, C., Galeone, C., Ruggiero, P., Yacoub, M. R., Berti, A., Colombo, G., Scichilone, N., Durante, C., Costantino, M. T., Roncallo, C., Braschi, M., Blasi, F., D'Adda, A., Ridolo, E., Triggiani, M., Parente, R., Maria, D. A., Verrillo, M. V., Cristina, Z. M., Lilli, M., Crimi, N., Bonavia, M., Corsico, A. G., Grosso, A., Del Giacco, S., Deidda, M., Ricciardi, L., Isola, S., Cicero, F., Amato, G., Vita, F., Spanevello, A., Pignatti, P., Cherubino, F., Visca, D., Aletti, E., Massimo Ricciardolo, F. L., Anna Carriero, V. M., Bertolini, F., Santus, P., Barlassina, R., Airoldi, A., Guida, G., Eleonora, N., Aruanno, A., Rizzi, A., Caruso, C., Colantuono, S., Arcolaci, A., Vianello, A., Bianchi, F. C., Marchi, M. R., Centanni, S., Luraschi, S., Ruggeri, S., Rinaldo, R., Parazzini, E., Calabrese, C., Flora, M., Cosmi, L., Di Pietro, L., Maggi, E., Pini, L., Macchia, L., Di Bona, D., Richeldi, L., Condoluci, C., Fuso, L., Bonini, M., Farsi, A., Carli, G., Montuschi, P., Santini, G., Conte, M. E., Turchet, E., Barbetta, C., Mazza, F., D'Alo, S., Pucci, S., Caiaffa, M. F., Minenna, E., D'Elia, L., Pasculli, C., Viviano, V., Tarsia, P., Rolo, J., Di Proietto, M., Lo Cicero, S., Bagnasco, Diego, Povero, Massimiliano, Pradelli, Lorenzo, Brussino, Luisa, Rolla, Giovanni, Caminati, Marco, Menzella, Francesco, Heffler, Enrico, Canonica, Giorgio Walter, Paggiaro, Pierluigi, Senna, Gianenrico, Milanese, Manlio, Lombardi, Carlo, Bucca, Caterina, Manfredi, Andrea, Canevari, Rikki Frank, Passalacqua, Giovanni, Guarnieri, Gabriella, Patella, Vincenzo, Foschino Barbaro, Maria Pia, Carpagnano, Elisiana, D' Amato, Maria, Verrillo, Mariavittoria, Zappa, Maria Cristina, Lo Cicero, Salvatore, Di Proietto, Maria Carmela, Walter Canonica, Giorgio, Frank Canevari, Rikki, Spadaro, Giuseppe, Bagnasco D., Povero M., Pradelli L., Brussino L., Rolla G., Caminati M., Menzella F., Heffler E., Canonica G.W., Paggiaro P., Senna G., Milanese M., Lombardi C., Bucca C., Manfredi A., Canevari R.F., Passalacqua G., Guarnieri G., Patella V., Maria Pia F.B., Carpagnano E., Colle A.D., Scioscia G., Gerolamo P., Latorre M., Puggioni F., Racca F., Favero E., Iannacone S., Savi E., Montagni M., Camiciottoli G., Allegrini C., Spadaro G., Detoraki C., Galeone C., Ruggiero P., Yacoub M.R., Berti A., Colombo G., Scichilone N., Durante C., Costantino M.T., Roncallo C., Braschi M., Blasi F., D'Adda A., Ridolo E., Triggiani M., Parente R., Maria D.A., Verrillo M.V., Cristina Z.M., Lilli M., Crimi N., Bonavia M., Corsico A.G., Grosso A., Del Giacco S., Deidda M., Ricciardi L., Isola S., Cicero F., Amato G., Vita F., Spanevello A., Pignatti P., Cherubino F., Visca D., Aletti E., Massimo Ricciardolo F.L., Anna Carriero V.M., Bertolini F., Santus P., Barlassina R., Airoldi A., Guida G., Eleonora N., Aruanno A., Rizzi A., Caruso C., Colantuono S., Arcolaci A., Vianello A., Bianchi F.C., Marchi M.R., Centanni S., Luraschi S., Ruggeri S., Rinaldo R., Parazzini E., Calabrese C., Flora M., Cosmi L., Di Pietro L., Maggi E., Pini L., Macchia L., Di Bona D., Richeldi L., Condoluci C., Fuso L., Bonini M., Farsi A., Carli G., Montuschi P., Santini G., Conte M.E., Turchet E., Barbetta C., Mazza F., D'Alo S., Pucci S., Caiaffa M.F., Minenna E., D'Elia L., Pasculli C., Viviano V., Tarsia P., Rolo J., Di Proietto M., Lo Cicero S.

المصدر: The World Allergy Organization Journal
World Allergy Organization Journal, Vol 14, Iss 2, Pp 100509-(2021)

مصطلحات موضوعية: OR, Odds Ratio, Pediatrics, Severe asthma, Exacerbation, Anti IL-5, Comorbidities, Mepolizumab, OCS, Pharmacoeconomics, gastroesophageal reflux disease, Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO, ICS, inhaled corticosteroid, Rate ratio, OCS, Oral Corticosteroids, law.invention, LAMA, long acting muscarinic antagonist, 0302 clinical medicine, Randomized controlled trial, fractional nitric oxide, Interquartile range, law, long acting beta 2 agonist, Odds Ratio, Immunology and Allergy, RR, Rate Ratio, 030223 otorhinolaryngology, Pharmacoeconomic, LOS, Length of stay, LOS, IQR, LAMA, MEP, Mepolizumab, OR, CI, SD, Standard Deviation, MEP, ACT, Asthma Control Test, Comorbiditie, CI, Confidence Intervals, medicine.drug, lcsh:Immunologic diseases. Allergy, Pulmonary and Respiratory Medicine, medicine.medical_specialty, interquartile range, long acting muscarinic antagonist, Immunology, LABA, LABA, long acting beta 2 agonist, Comorbidities, Mepolizumab, OCS, Pharmacoeconomics, Severe asthma, Anti IL-5, RR, Article, Rate Ratio, chronic obstructive pulmonary disease, 03 medical and health sciences, OCS, Oral Corticosteroid, Asthma Control Test, Confidence Intervals, FeNO, fractional nitric oxide, RCTs, Randomized Controlled Trial, medicine, COPD, GERD, gastroesophageal reflux disease, FeNO, IQR, interquartile range, SD, Asthma, RCTs, Oral Corticosteroids, business.industry, GERD, medicine.disease, ICS, inhaled corticosteroids, ACT, Comorbidity, Randomized Controlled Trials, CI, Confidence Interval, RCTs, Randomized Controlled Trials, COPD, chronic obstructive pulmonary disease, 030228 respiratory system, ICS, Standard Deviation, Length of stay, inhaled corticosteroids, lcsh:RC581-607, business

الوصف: Background and aims Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patients. Methods Patients >18 years old, referred to 8 asthma clinics, starting MEP between May 2017 and December 2018, were enrolled and followed-up for 12 months. Information in the 12 months before mepolizumab were collected retrospectively. The evaluation parameters included: OCS use, number of exacerbations/hospitalizations, concomitant therapies, comorbidity, and annual number of working days lost due to the disease. The primary objective was to compare the annual total cost per patient pre- and post-MEP. Secondary outcomes included rates of exacerbations and number of OCS-dependent patients. Results 106 patients were enrolled in the study: 46 male, median age 58 years. Mean annual cost pre- and post-MEP (cost of biologic excluded) was €3996 and €1,527, respectively. Total savings due to MEP resulted in €2469 (95%CI 1945–2993), 62% due to exacerbations reduction and 33% due to productivity increase. Such savings could fund about 22% of the total cost of MEP for one year. The introduction of MEP induced a clinical benefit by reducing both OCS-dependent patients (OR = 0.12, 95%CI 0.06–0.23) and exacerbation rate (RR = 0.19, 95%CI 0.15–0.24). Conclusions Patients with severe eosinophilic asthma experienced a clinical benefit in asthma control adding MEP to standard therapy. Biologic therapy can be, partially, funded by the savings produced by patients’ improvement.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bfb550cc9a8e46383180770c7c39eeTest
https://hdl.handle.net/11567/1039731Test

المؤلفون: G Garcia, C. Chenivesse, Arnaud Bourdin, C. Taille, G Devouassoux

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), MORNET, Dominique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Respiratory Medicine and Research
Respiratory Medicine and Research, Elsevier, 2020, 78, pp.100762. ⟨10.1016/j.resmer.2020.100762⟩
Respiratory Medicine and Research, 2020, 78, pp.100762. ⟨10.1016/j.resmer.2020.100762⟩

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, 2019-20 coronavirus outbreak, ACT, asthma control test, Coronavirus disease 2019 (COVID-19), SAMA, short acting muscarinic antagonists, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), [SDV]Life Sciences [q-bio], Physical Distancing, Article, ACQ, asthma control questionnaire, NSAIDS, non-steroidal anti-inflammatory drugs, 03 medical and health sciences, 0302 clinical medicine, OCS, oral corticosteroids, Pulmonary Medicine, Medicine, Humans, 030212 general & internal medicine, Anti-Asthmatic Agents, LTRA, leukotriene receptor antagonists, Practice Patterns, Physicians', Pandemics, Societies, Medical, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, Asthma, 0303 health sciences, business.industry, SARS-CoV-2, Nebulizers and Vaporizers, Outbreak, COVID-19, LAMA, long acting muscarinic antagonists, medicine.disease, Virology, ICS, inhaled corticosteroids, [SDV] Life Sciences [q-bio], Disease Progression, FFP, filtering face-piece, France, business, Public Health Administration, SABA, short acting beta-2 agonists, LABA, long acting beta-2 agonists

الوصف: International audience

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6359773d8c9acbb7d9347ac57316ff1bTest
https://hal.archives-ouvertes.fr/hal-02917545/documentTest

المؤلفون: 齋藤, 暁, Saito, Akira

مصطلحات موضوعية: 気管支喘息, ソーシャルキャピタル, ACT(Asthma Control Test), アンケート調査

الوصف: 新潟大学 ; Niigata University ; 博士（医学） ; ソーシャルキャピタルは, 社会組織の重要性を説明する概念である. ソーシャルキャピタルと慢性疾患の関連はいくつか報告されているが, 喘息コントロールとソーシャルキャピタルの関係は明らかでない. 今回, 我々は, アンケート調査を用いて喘息コントロールとソーシャルキャピタルの関係を調査した. 新潟県内の医療機関に通院している喘息患者とその主治医を対象に, 2016年9月から10月にかけて横断的な喘息コントロール状況, 治療内容などのアンケート調査を実施した. 個々のソーシャルキャピタルは, 日本老年学的評価研究機構(JAGES: Japan Gerontological Evaluation Study)のソーシャルキャピタル測定法を用いて評価した. 解析対象は, 1659人で, 喘息コントロールテスト(ACT: Asthma Control Test)でコントロール良好群（ACT≥23）は898名, コントロール不十分群（ACT<23）は761名であった. コントロール不十分群では, コントロール良好群と比較して有意に, 喫煙歴およびASK-12(Adherence Starts with Knowledge-12)は高く, 重症の割合が多く, より多くの治療薬が使用されていた. ソーシャルキャピタルは, コントロール良好群でより高く, 特に社会的連帯の項目においては, コントロール良好群では, コントロール不十分群よりも明らかに良好であった. 名義ロジスティック解析により, BMI(Body Mass Index), 喫煙, ASK-12は喘息コントロールに独立した関連因子であることを示した. それに加えて, ソーシャルキャピタルの社会的連帯は, 喘息コントロールに独立した関連因子であることを示した. ソーシャルキャピタル良好群とソーシャルキャピタル不十分群を比較した解析では, ソーシャルキャピタル良好群ではソーシャルキャピタル不十分群と比較して, 喫煙率, ASK-12, 重症の割合は低く, ACT スコアは高い結果であった. 以上より, 喘息コントロールに関与する要因として, ソーシャルキャピタルなどの社会背景は重要であると考えられた. ; 新大院博(医)第1030号 ; doctoral thesis

وصف الملف: application/pdf

العلاقة: 甲第4940号; https://niigata-u.repo.nii.ac.jp/record/2000472/files/r3nmk1030.pdfTest; https://niigata-u.repo.nii.ac.jp/record/2000472/files/r3nmk1030_a.pdfTest

الإتاحة: https://niigata-u.repo.nii.ac.jp/record/2000472/files/r3nmk1030.pdfTest
https://niigata-u.repo.nii.ac.jp/record/2000472/files/r3nmk1030_a.pdfTest

المؤلفون: Jay M. Portnoy, Yudy K. Persaud

المصدر: The Journal of Allergy and Clinical Immunology. in Practice

مصطلحات موضوعية: Telemedicine, Specialty, RPM, Remote Patient Monitoring, Telehealth, 03 medical and health sciences, 0302 clinical medicine, Immunology and Allergy, Medicine, Humans, 030212 general & internal medicine, FVV, Facilitated Virtual Visits, Pandemics, CMS, Center for Medicare and Medicaid Services, business.industry, SARS-CoV-2, Health Insurance Portability and Accountability Act, Rostrum, CPT, Current Procedural Terminology, M-Health, Mobile Health, COVID-19, IMLC, Interstate Medical Licensure Compact, medicine.disease, Mental health, Digital health, Asthma, DTC, Direct to Consumer, HIPAA, Health Insurance Portability and Accountability Act, ACT, Asthma Control Test, 030228 respiratory system, COVID-19, Coronavirus Disease 2019, Connected health, TM, Telemedicine, Allergists, Medical emergency, business

الوصف: During the coronavirus disease 2019 (COVID-19) pandemic, the use of telemedicine changed from being an optional way to see patients to becoming a necessity. It has transformed primary, specialty, and mental health services by becoming incorporating into everyday practice. Because allergists have adapted to patient care using telemedicine, use of this technology is likely to continue after COVID-19. In the process of using telemedicine, lessons have been learned. We now offer 10 rules for creating a successful telemedicine practice while also ensuring that quality asthma care is provided.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f70d5400b2a68c0a64bc69dd629945Test
https://pubmed.ncbi.nlm.nih.gov/33039648Test

المؤلفون: Sanaz Eftekhari, Nadeen Sarsour, Hannah Jaffee, Priya Bansal, Laurie Carpenter, Alan P. Baptist, Desmond Lowe

المصدر: The Journal of Allergy and Clinical Immunology. in Practice

مصطلحات موضوعية: Male, Health Knowledge, Attitudes, Practice, Severity of Illness Index, 0302 clinical medicine, Surveys and Questionnaires, Pandemic, Immunology and Allergy, Medicine, 030212 general & internal medicine, Anti-Asthmatic Agents, Survey, CDC, Centers for Disease Control and Prevention, Medically Uninsured, Hispanic or Latino, Health equity, ACT, Asthma Control Test, Pulmonologists, Female, Original Article, Coronavirus Infections, Adult, medicine.medical_specialty, Pneumonia, Viral, Implicit bias, Social class, Physicians, Primary Care, White People, 03 medical and health sciences, Betacoronavirus, Racism, Humans, Healthcare Disparities, Socioeconomic status, Pandemics, Structural racism, Asthma, business.industry, SARS-CoV-2, Public health, Primary care physician, COVID-19, Odds ratio, Health Status Disparities, medicine.disease, United States, LABA, Long-acting beta-agonist, Black or African American, 030228 respiratory system, Social Class, Unemployment, Family medicine, Attitudes, Institutional racism, Health disparities, business, OR, Odds ratio

الوصف: Background The coronavirus disease 2019 (COVID-19) pandemic has demonstrated significantly worse outcomes for minority (black and Hispanic) individuals. Understanding the reasons for COVID-19–related disparities among patients with asthma has important public health implications. Objective To determine factors contributing to health disparities in those with asthma during the COVID-19 pandemic. Methods An anonymous survey was sent through social media to adult patients with asthma, and a separate survey was sent to physicians who provide asthma care. The patient survey addressed demographic information including socioeconomic status, asthma control, and attitudes/health behaviors during COVID-19. Results A total of 1171 patients (10.1% minority individuals) and 225 physicians completed the survey. Minority patients were more likely to have been affected by COVID-19 (eg, became unemployed, lived in a community with high COVID-19 cases). They had worse asthma control (increased emergency visits for asthma, lower Asthma Control Test score), were more likely to live in urban areas, and had a lower household income. Initial differences in attitudes and health behaviors disappeared after controlling for baseline demographic features. Institutional racism was demonstrated by findings that minority individuals were less likely to have a primary care physician, had more trouble affording asthma medications due to COVID-19, and were more likely to have lost health insurance because of COVID-19, and that 25% of physicians found it more challenging to care for black individuals with asthma during COVID-19. Conclusions Differences in socioeconomic status and the effects of institutional racism, but not health behaviors, sources of information, or attitudes, are playing a role in disparities seen for patients with asthma during COVID-19.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72dd2c6e42a28ee395a78059a341766dTest
https://pubmed.ncbi.nlm.nih.gov/32980585Test